Detail page

Knowledge Web

Person

Mark Kriegsmann (1987-)

Pathologe

Name	Mark Kriegsmann
Time	1987- (Date of birth and death)
Place	Jena (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Gender	männlich
Academic degree	PD Dr. med.
Profession	Pathologe (characteristic profession)
Variant	Mark Bert Kriegsmann M. Kriegsmann
Related	Klinikum Heidelberg (Allgemeine Pathologie und Pathologische Anatomie, Oberarzt)
Further information	Promotion an der Universität Leipzig 2013; Habilitation an der Universität Heidelberg 2019
Record type	Person
GND-Identifier	103740324X
Record ID	103740324X
Involved in show all PITX2 as a sensitive and specific marker of midgut neuroendocrine tumors: results from a cohort of 1157 primary neuroendocrine neoplasms Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities Proteogenomics refines the molecular classification of chronic lymphocytic leukemia Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis Robust subtyping of non‐small cell lung cancer whole sections through MALDI mass spectrometry imaging Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples Cryostorage to What End? – Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution Microproteomics and Immunohistochemistry Reveal Differences in Aldo‐Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy Massenspektrometrische Charakterisierung solider Neoplasien DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma Identification of MALDI Imaging Proteolytic Peptides Using LC‐MS/MS‐Based Biomarker Discovery Data: A Proof of Concept In MALDI–Mass Spectrometry Imaging on Formalin‐Fixed Paraffin‐Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity Increases in Tumor N‐Glycan Polylactosamines Associated with Advanced HER2‐Positive and Triple‐Negative Breast Cancer Tissues MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures Microproteomic Profiling of High‐Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic Markers Proteomics in Pathology: The Special Issue Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer Cell-based immunotherapy approaches for multiple myeloma Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry Spinale Mammakarzinommetastasen aus Sicht der Wirbelsäulenchirurgie : Prädiktoren auf Molekularebene zur Wahl der adäquaten Therapiestrategie Proteomics in Pathology HCV load as a possible prognostic factor in patients with HCV-related DLBCL Die neue TNM-Klassifikation für Lungentumoren : Änderungen und Bewertung multipler Tumorherde PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma Die neue TNM-Klassifikation für Lungentumoren : Änderungen und Bewertung multipler Tumorherde Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis MALDI mass spectrometry imaging: A cutting‐edge tool for fundamental and clinical histopathology Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation MALDI MS Imaging zur Untersuchung von synovialem Gewebe

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Mark Kriegsmann (1987-)

PITX2 as a sensitive and specific marker of midgut neuroendocrine tumors: results from a cohort of 1157 primary neuroendocrine neoplasms

Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score

Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

Robust subtyping of non‐small cell lung cancer whole sections through MALDI mass spectrometry imaging

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Cryostorage to What End? – Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican

Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution

Microproteomics and Immunohistochemistry Reveal Differences in Aldo‐Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease

Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy

Massenspektrometrische Charakterisierung solider Neoplasien

DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics

Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells

DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information

Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging

Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma

Identification of MALDI Imaging Proteolytic Peptides Using LC‐MS/MS‐Based Biomarker Discovery Data: A Proof of Concept

In MALDI–Mass Spectrometry Imaging on Formalin‐Fixed Paraffin‐Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity

Increases in Tumor N‐Glycan Polylactosamines Associated with Advanced HER2‐Positive and Triple‐Negative Breast Cancer Tissues

MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures

Microproteomic Profiling of High‐Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic Markers

Proteomics in Pathology: The Special Issue

Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples

Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer

Cell-based immunotherapy approaches for multiple myeloma

Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer

Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study

Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry

Spinale Mammakarzinommetastasen aus Sicht der Wirbelsäulenchirurgie : Prädiktoren auf Molekularebene zur Wahl der adäquaten Therapiestrategie

Proteomics in Pathology

HCV load as a possible prognostic factor in patients with HCV-related DLBCL

Die neue TNM-Klassifikation für Lungentumoren : Änderungen und Bewertung multipler Tumorherde

PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Die neue TNM-Klassifikation für Lungentumoren : Änderungen und Bewertung multipler Tumorherde

Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result

Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis

MALDI mass spectrometry imaging: A cutting‐edge tool for fundamental and clinical histopathology

Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases

Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique

Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation

Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues

Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation

MALDI MS Imaging zur Untersuchung von synovialem Gewebe